Multiple sclerosis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 21: Line 21:
* '''syphilis:''' [[Neurosyphilis]], more commonly seen in [[HIV|HIV+]] patients can be in two forms. One can be seen in late secondary or early tertiary stages as meningovascular involvement and the other one can be seen in later stages as [[parenchymal]] involvement. Meningovascular lesions can present like a [[stroke]] while the other one cause gummas (contrast enhancing lesions). In [[CSF]] there are evidences of [[oligoclonal bands]], [[pleocytosis]] and elevated [[gammaglobulin]].<ref name="pmid16808833">{{cite journal |vauthors=Fadil H, Gonzalez-Toledo E, Kelley BJ, Kelley RE |title=Neuroimaging findings in neurosyphilis |journal=J Neuroimaging |volume=16 |issue=3 |pages=286–9 |year=2006 |pmid=16808833 |doi=10.1111/j.1552-6569.2006.00050.x |url=}}</ref>
* '''syphilis:''' [[Neurosyphilis]], more commonly seen in [[HIV|HIV+]] patients can be in two forms. One can be seen in late secondary or early tertiary stages as meningovascular involvement and the other one can be seen in later stages as [[parenchymal]] involvement. Meningovascular lesions can present like a [[stroke]] while the other one cause gummas (contrast enhancing lesions). In [[CSF]] there are evidences of [[oligoclonal bands]], [[pleocytosis]] and elevated [[gammaglobulin]].<ref name="pmid16808833">{{cite journal |vauthors=Fadil H, Gonzalez-Toledo E, Kelley BJ, Kelley RE |title=Neuroimaging findings in neurosyphilis |journal=J Neuroimaging |volume=16 |issue=3 |pages=286–9 |year=2006 |pmid=16808833 |doi=10.1111/j.1552-6569.2006.00050.x |url=}}</ref>
* '''Progressive multifocal leukoencephalopathy:''' [[Progressive multifocal leukoencephalopathy]] ([[Progressive multifocal leukoencephalopathy|PML]]) is cause by activation of [[JC virus]] and is more commonly seen in [[immunocompromised]] patients. Some evidences shows the relation between [[Progressive multifocal leukoencephalopathy|PML]] and drug [[natalizumab]].<ref name="pmid15947082">{{cite journal |vauthors=Berger JR, Koralnik IJ |title=Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences |journal=N. Engl. J. Med. |volume=353 |issue=4 |pages=414–6 |year=2005 |pmid=15947082 |doi=10.1056/NEJMe058122 |url=}}</ref> In [[MRI]] of [[Progressive multifocal leukoencephalopathy|PML]] patients we see multiple [[white matter]] lesions that can become confluent with no enhancement in T1. Diagnosis of [[Progressive multifocal leukoencephalopathy|PML]] is bases on detecting [[JC virus]] in [[CSF]].<ref name="pmid20299430">{{cite journal |vauthors=Bag AK, Curé JK, Chapman PR, Roberson GH, Shah R |title=JC virus infection of the brain |journal=AJNR Am J Neuroradiol |volume=31 |issue=9 |pages=1564–76 |year=2010 |pmid=20299430 |doi=10.3174/ajnr.A2035 |url=}}</ref><ref name="pmid20451009">{{cite journal |vauthors=Shah R, Bag AK, Chapman PR, Curé JK |title=Imaging manifestations of progressive multifocal leukoencephalopathy |journal=Clin Radiol |volume=65 |issue=6 |pages=431–9 |year=2010 |pmid=20451009 |doi=10.1016/j.crad.2010.03.001 |url=}}</ref>
* '''Progressive multifocal leukoencephalopathy:''' [[Progressive multifocal leukoencephalopathy]] ([[Progressive multifocal leukoencephalopathy|PML]]) is cause by activation of [[JC virus]] and is more commonly seen in [[immunocompromised]] patients. Some evidences shows the relation between [[Progressive multifocal leukoencephalopathy|PML]] and drug [[natalizumab]].<ref name="pmid15947082">{{cite journal |vauthors=Berger JR, Koralnik IJ |title=Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences |journal=N. Engl. J. Med. |volume=353 |issue=4 |pages=414–6 |year=2005 |pmid=15947082 |doi=10.1056/NEJMe058122 |url=}}</ref> In [[MRI]] of [[Progressive multifocal leukoencephalopathy|PML]] patients we see multiple [[white matter]] lesions that can become confluent with no enhancement in T1. Diagnosis of [[Progressive multifocal leukoencephalopathy|PML]] is bases on detecting [[JC virus]] in [[CSF]].<ref name="pmid20299430">{{cite journal |vauthors=Bag AK, Curé JK, Chapman PR, Roberson GH, Shah R |title=JC virus infection of the brain |journal=AJNR Am J Neuroradiol |volume=31 |issue=9 |pages=1564–76 |year=2010 |pmid=20299430 |doi=10.3174/ajnr.A2035 |url=}}</ref><ref name="pmid20451009">{{cite journal |vauthors=Shah R, Bag AK, Chapman PR, Curé JK |title=Imaging manifestations of progressive multifocal leukoencephalopathy |journal=Clin Radiol |volume=65 |issue=6 |pages=431–9 |year=2010 |pmid=20451009 |doi=10.1016/j.crad.2010.03.001 |url=}}</ref>
* '''HTLV-1 infection:''' Human T lymphotrophic virus, transmitted through sexual activity, can cause tropical spastic paraparesis.<ref name="pmid12619783">{{cite journal |vauthors=Howard AK, Li DK, Oger J |title=MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives |journal=Can J Neurol Sci |volume=30 |issue=1 |pages=41–8 |year=2003 |pmid=12619783 |doi= |url=}}</ref> The involvement of spinal cord and MRI pattern of Tropical spastic paraparesis can mimic MS disease.<ref name="pmid16338746">{{cite journal |vauthors=Bagnato F, Butman JA, Mora CA, Gupta S, Yamano Y, Tasciyan TA, Solomon JM, Santos WJ, Stone RD, McFarland HF, Jacobson S |title=Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis |journal=J. Neurovirol. |volume=11 |issue=6 |pages=525–34 |year=2005 |pmid=16338746 |doi=10.1080/13550280500385039 |url=}}</ref> In CSF we have positive HTLV-1 titer, lymphocytic pleocytosis, oligoclonal bands and high level of proteins.<ref name="pmid16434682">{{cite journal |vauthors=Umehara F, Tokunaga N, Hokezu Y, Hokonohara E, Yoshishige K, Shiraishi T, Okubo R, Osame M |title=Relapsing cervical cord lesions on MRI in patients with HTLV-I-associated myelopathy |journal=Neurology |volume=66 |issue=2 |pages=289 |year=2006 |pmid=16434682 |doi=10.1212/01.wnl.0000194219.89668.66 |url=}}</ref>
* '''HTLV-1 infection:''' [[Human T-lymphotropic virus|Human T]] lymphotrophic virus, transmitted through sexual activity, can cause [[tropical spastic paraparesis]].<ref name="pmid12619783">{{cite journal |vauthors=Howard AK, Li DK, Oger J |title=MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives |journal=Can J Neurol Sci |volume=30 |issue=1 |pages=41–8 |year=2003 |pmid=12619783 |doi= |url=}}</ref> The involvement of [[spinal cord]] and [[MRI]] pattern of [[Tropical spastic paraparesis]] can mimic [[MS]] disease.<ref name="pmid16338746">{{cite journal |vauthors=Bagnato F, Butman JA, Mora CA, Gupta S, Yamano Y, Tasciyan TA, Solomon JM, Santos WJ, Stone RD, McFarland HF, Jacobson S |title=Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis |journal=J. Neurovirol. |volume=11 |issue=6 |pages=525–34 |year=2005 |pmid=16338746 |doi=10.1080/13550280500385039 |url=}}</ref> In [[CSF]] we have positive [[Human T-lymphotropic virus|HTLV-1]] titer, [[Lymphocyte|lymphocytic]] [[pleocytosis]], [[oligoclonal bands]] and high level of proteins.<ref name="pmid16434682">{{cite journal |vauthors=Umehara F, Tokunaga N, Hokezu Y, Hokonohara E, Yoshishige K, Shiraishi T, Okubo R, Osame M |title=Relapsing cervical cord lesions on MRI in patients with HTLV-I-associated myelopathy |journal=Neurology |volume=66 |issue=2 |pages=289 |year=2006 |pmid=16434682 |doi=10.1212/01.wnl.0000194219.89668.66 |url=}}</ref>
* '''HIV-Related Disorders of the CNS:'''  
* '''HIV-Related Disorders of the CNS:''' HIV infection frequently involves CNS and can be the initial manifestation of the disease. In MRI there are white matter lesions and in CSF analysis there are high levels of proteins and cell counts but oligoclonal bands are rarely seen.


==== Metabolic and genetic disorders: ====
==== Metabolic and genetic disorders: ====

Revision as of 09:09, 18 February 2018

Multiple sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Alternative Therapies

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple sclerosis differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple sclerosis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple sclerosis differential diagnosis

CDC on Multiple sclerosis differential diagnosis

Multiple sclerosis differential diagnosis in the news

Blogs on Multiple sclerosis differential diagnosis

Directions to Hospitals Treating Multiple sclerosis

Risk calculators and risk factors for Multiple sclerosis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

  • Overview

Differentiating multiple sclerosis from other diseases

Multiple sclerosis must be differentiated from other diseases that can mimic this disease clinically or radiologically such as:

Inflammatory/autoimmune conditions:

Infections:

Metabolic and genetic disorders:

  • Vitamin B12 deficiency:
  • Lysosomal disorders:
  • Adrenoleukodystrophy:
  • Mitochondrial disorders:
  • Clinically defined genetic disorders:

CNS lymphoma

spinal diseases

References

Template:WH Template:WS

  1. Barned S, Goodman AD, Mattson DH (1995). "Frequency of anti-nuclear antibodies in multiple sclerosis". Neurology. 45 (2): 384–5. PMID 7854544.
  2. Alexander EL, Malinow K, Lejewski JE, Jerdan MS, Provost TT, Alexander GE (1986). "Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis". Ann. Intern. Med. 104 (3): 323–30. PMID 3946977.
  3. Calabrese LH, Furlan AJ, Gragg LA, Ropos TJ (1992). "Primary angiitis of the central nervous system: diagnostic criteria and clinical approach". Cleve Clin J Med. 59 (3): 293–306. PMID 1516217.
  4. Calabrese LH, Duna GF, Lie JT (1997). "Vasculitis in the central nervous system". Arthritis Rheum. 40 (7): 1189–201. doi:10.1002/1529-0131(199707)40:7&lt;1189::AID-ART2&gt;3.0.CO;2-4. PMID 9214418.
  5. Berger JR, Wei T, Wilson D (1998). "Idiopathic granulomatous angiitis of the CNS manifesting as diffuse white matter disease". Neurology. 51 (6): 1774–5. PMID 9855557.
  6. Moore PM (1989). "Diagnosis and management of isolated angiitis of the central nervous system". Neurology. 39 (2 Pt 1): 167–73. PMID 2915784.
  7. Kidd D, Steuer A, Denman AM, Rudge P (1999). "Neurological complications in Behçet's syndrome". Brain. 122 ( Pt 11): 2183–94. PMID 10545402.
  8. Akman-Demir G, Serdaroglu P, Tasçi B (1999). "Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group". Brain. 122 ( Pt 11): 2171–82. PMID 10545401.
  9. Sharief MK, Hentges R, Thomas E (1991). "Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behçet's disease". Neurology. 41 (9): 1398–401. PMID 1891089.
  10. Tali ET, Atilla S, Keskin T, Simonson T, Işik S, Yuh WT (1997). "MRI in neuro-Behçet's disease". Neuroradiology. 39 (1): 2–6. PMID 9121642.
  11. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J (1985). "Sarcoidosis and its neurological manifestations". Arch. Neurol. 42 (9): 909–17. PMID 3896208.
  12. Sharma OP (1997). "Neurosarcoidosis: a personal perspective based on the study of 37 patients". Chest. 112 (1): 220–8. PMID 9228380.
  13. Smith AS, Meisler DM, Weinstein MA, Tomsak RL, Hanson MR, Rudick RA, Farris BK, Ransohoff RM (1989). "High-signal periventricular lesions in patients with sarcoidosis: neurosarcoidosis or multiple sclerosis?". AJR Am J Roentgenol. 153 (1): 147–52. doi:10.2214/ajr.153.1.147. PMID 2735279.
  14. McLean BN, Miller D, Thompson EJ (1995). "Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system". J. Neurol. Neurosurg. Psychiatry. 58 (5): 548–54. PMC 1073484. PMID 7745401.
  15. Hughes GR (1983). "Thrombosis, abortion, cerebral disease, and the lupus anticoagulant". Br Med J (Clin Res Ed). 287 (6399): 1088–9. PMC 1549319. PMID 6414579.
  16. Levine SR, Deegan MJ, Futrell N, Welch KM (1990). "Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases". Neurology. 40 (8): 1181–9. PMID 2381525.
  17. Ferreira S, D'Cruz DP, Hughes GR (2005). "Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?". Rheumatology (Oxford). 44 (4): 434–42. doi:10.1093/rheumatology/keh532. PMID 15644391.
  18. Susac JO, Murtagh FR, Egan RA, Berger JR, Bakshi R, Lincoff N, Gean AD, Galetta SL, Fox RJ, Costello FE, Lee AG, Clark J, Layzer RB, Daroff RB (2003). "MRI findings in Susac's syndrome". Neurology. 61 (12): 1783–7. PMID 14694047.
  19. Drozdowski W (2006). "[Multifocal central nervous system lesions --multiple sclerosis or neuroborreliosis?]". Przegl Epidemiol (in Polish). 60 Suppl 1: 39–45. PMID 16909774.
  20. Fadil H, Gonzalez-Toledo E, Kelley BJ, Kelley RE (2006). "Neuroimaging findings in neurosyphilis". J Neuroimaging. 16 (3): 286–9. doi:10.1111/j.1552-6569.2006.00050.x. PMID 16808833.
  21. Berger JR, Koralnik IJ (2005). "Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences". N. Engl. J. Med. 353 (4): 414–6. doi:10.1056/NEJMe058122. PMID 15947082.
  22. Bag AK, Curé JK, Chapman PR, Roberson GH, Shah R (2010). "JC virus infection of the brain". AJNR Am J Neuroradiol. 31 (9): 1564–76. doi:10.3174/ajnr.A2035. PMID 20299430.
  23. Shah R, Bag AK, Chapman PR, Curé JK (2010). "Imaging manifestations of progressive multifocal leukoencephalopathy". Clin Radiol. 65 (6): 431–9. doi:10.1016/j.crad.2010.03.001. PMID 20451009.
  24. Howard AK, Li DK, Oger J (2003). "MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives". Can J Neurol Sci. 30 (1): 41–8. PMID 12619783.
  25. Bagnato F, Butman JA, Mora CA, Gupta S, Yamano Y, Tasciyan TA, Solomon JM, Santos WJ, Stone RD, McFarland HF, Jacobson S (2005). "Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis". J. Neurovirol. 11 (6): 525–34. doi:10.1080/13550280500385039. PMID 16338746.
  26. Umehara F, Tokunaga N, Hokezu Y, Hokonohara E, Yoshishige K, Shiraishi T, Okubo R, Osame M (2006). "Relapsing cervical cord lesions on MRI in patients with HTLV-I-associated myelopathy". Neurology. 66 (2): 289. doi:10.1212/01.wnl.0000194219.89668.66. PMID 16434682.